Dear Biopharmaceutical Marketer:

BioPharm International’s parent company, Advanstar Communications recognizes that biopharmaceutical manufacturing is a strong, vibrant and growing industry and that is why I am excited to become BioPharm International’s new publisher. You may have recognized some recent investments including the appointment of Michelle Hoffman as editorial director. Michelle has advanced training in molecular biology, years of experience in the pharmaceutical and biotech industries and an MBA in corporate finance. I am pleased to work with an editor whose curriculum vitae matches our tagline, The Science & Business of Pharmaceuticals. My employment and dedication to the BioPharm International brand is another investment in an evolving list. With over 20 years of media management, I will be dedicated to developing new and innovative ways of reaching our 30,000 plus readers and over 24,000 unique website visitors each month.

I will focus on providing even greater communication between our sales team and you, our business partners, by offering advanced notice on upcoming opportunities to effectively deliver your media message to your prospects and customers. My role will include listening to you about your marketing objectives and media goals then providing solutions to meet your needs.

We’ll continue to monitor our readers to produce more efficient delivery of our content. We’ll also continue to field queries on future purchasing plans and provide market intelligence to those associated with BioPharm International. We plan to be online, in print, in person or wherever your customers and prospects are to offer you a more complete media partner.

These are BioPharm International’s goals and in the coming weeks, I hope to be communicating with you about yours.

Please feel free to contact me at any time,

Allen Basis
Publisher
BioPharm International
(o) 732-346-3013
www.BioPharmInternational.com

The Science & Business of Biopharmaceuticals